Page last updated: 2024-11-05

tropicamide and Lacrimal Duct Obstruction

tropicamide has been researched along with Lacrimal Duct Obstruction in 1 studies

Tropicamide: One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.

Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loewenstein, A1
Sadeh, A1
Goldstein, M1
Lazar, M1

Trials

1 trial available for tropicamide and Lacrimal Duct Obstruction

ArticleYear
The effect of nasolacrimal occlusion on drug-induced mydriasis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1995, Volume: 233, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Double-Blind Method; Humans; Lacrimal Duct Obs

1995